Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy

Ludger Klimek1, Sophia C Poletti2, Annette Sperl1

  • 1Zentrum für Rhinologie und Allergologie, Wiesbaden, Germany.

Abstract

Insights

MP-AzeFlu significantly improved olfaction and reduced nasal symptoms in allergic rhinitis patients. Severity of allergic rhinitis impacts olfactory function, suggesting olfaction assessment can gauge treatment success.

Area of Science:

  • Allergy and Immunology
  • Rhinology
  • Neuroscience

Background:

  • Persistent allergic rhinitis often impairs olfaction.
  • The relationship between allergic rhinitis severity and olfactory function requires further investigation.

Purpose of the Study:

  • To evaluate the impact of MP-AzeFlu on olfactory function in patients with persistent allergic rhinitis.
  • To explore the interaction between allergic rhinitis severity and olfactory improvement following MP-AzeFlu therapy.

Main Methods:

  • Prospective, multicenter observational study involving 47 patients with persistent allergic rhinitis.
  • Olfactory function assessed using the "Sniffin' Sticks" test at baseline and after 1 and 3 months of MP-AzeFlu treatment.
  • Allergic rhinitis severity classified using modified ARIA criteria; nasal symptoms recorded via VAS.

Main Results:

  • MP-AzeFlu treatment led to significant improvements in TDI scores (23.7 to 37.1) and VAS scores (84.3 to 26.2) over 3 months (p < 0.001).
  • A significant interaction was observed between allergic rhinitis severity and both olfactory function (p < 0.001) and VAS scores (p < 0.001).

Conclusions:

  • MP-AzeFlu is associated with significant olfactory improvement in patients with persistent allergic rhinitis.
  • Modified ARIA severity classification effectively indicates patients' olfactory function.
  • Olfactory assessment serves as a reliable measure of clinical success for antiallergic/anti-inflammatory therapies.

Related Concept Videos

Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
13.6K
Olfaction01:25

Olfaction

The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
49.5K
Physiology of Smell and Olfactory Pathway01:20

Physiology of Smell and Olfactory Pathway

Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
13.6K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
825
Assessment of Respiration01:23

Assessment of Respiration

The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
2.2K
Respiratory System Abnormal Finding II: Palpation and Auscultation01:31

Respiratory System Abnormal Finding II: Palpation and Auscultation

In assessing respiratory abnormalities, palpation and auscultation are critical tools for detecting and interpreting various pathophysiological changes. These techniques provide insight into underlying disorders by evaluating tactile sensations and sounds produced by the respiratory system.
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
1.8K